orasure.com - OSUR Net Assets per Single Share

Graphic logo of OraSure Technologies, Inc. (OSUR)

The OraSure Technologies (OSUR) market price chart illustrates the performance of a company specializing in diagnostic laboratory testing. Entry into the sector is restricted by complex FDA certification and patents for rapid saliva tests, which constitutes 4.62. Business stability is supported by dominance in the biomaterial collection niche, although the risk of declining demand for COVID products and competitor pressure in the over-the-counter segment could limit revenue.

OraSure Technologies, Inc. (OSUR) - Accounting Value per Share from 07/04/2022 to 10/27/2026

Summary analytical data breakdowns for orasure.com (OSUR)

- price and consensus price forecast:
Stock Quotes OraSure Technologies Inc|OSUR - Analyst Consensus Forecast
- market capitalization data:
Market Value OraSure Technologies|OSUR - Value Adjusted for Debt and Cash
- book capitalization data:
Net Assets per Single Share OraSure|OSUR - Company Net Assets|Market Capitalization to Book Value Ratio orasure.com|OSUR - Company Assets
- debt and liquidity data:
Total Debt to Capital OraSure Technologies|OSUR - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital OraSure|OSUR - Company Aggregate Debts|Debt to Book Capitalization Ratio OraSure Technologies
Fundamental company valuation:OraSure Technologies
Manufactured product of orasure.com

Analyzing fundamental risks through the share of net assets allows investors to filter out market noise and assess the real value of the business. OraSure Technologies (OSUR) investments in line robotization and AI platforms are reflected in the book value per share data, which shows the actual amount of capital per share, helping investors detect asset degradation in a timely manner or confirm the stability of the capitalization.

Competitors of OraSure Technologies (OSUR)

Agilent Tech - Accounting Value per Share|DGX: Book Value per Share|Net Assets per Single Share Illumina, Inc. ILMN|EXAS (exactsciences.com) - Accounting Value of a Share|Net Assets per Single Share RVTY|Accounting Value per Share Bio-Rad Laboratories, Inc.|Anbio Tech - Book Value per Share|Net Asset Value per Share Nordion (SHC)|QDEL - Book Value per Share|Equity per Share opko.com OPK|CareDx, Inc - Book Value per Share|MRVI: Book Value per Share|Net Assets per Single Share Fulgent Corp|Standard BioTools Corp (LAB) - Equity per Share|CTKB (Cytek Biosciences, Inc.) - Book Value per Share|Book Value per Share XGN|Net Assets per Single Share MDxHealth (MDXH)|Net Assets per Single Share Lucid Diagnostics, Inc. LUCD|PRE: Accounting Value per Share|Insight Molecular Diagnostics, Inc. - Net Asset Value per Share|Net Assets per Single Share TRIB (Trinity Biotech Corp)|PRPH - Net Assets per Share|Ainos - Book Value per Share|CODX (Co-Diagnostics Inc) - Net Assets per Share|HSCS: Net Assets per Single Share|Net Assets per Share BMRA|Cardio Diagnostics - Net Assets per Single Share|Net Asset Value per Share VRAX (viraxbiolabs.com)|Net Assets per Single Share Bluejay Diagnostics, Inc.|Accounting Value of a Share Aspira Women's Health, Inc. AWH|Accelerate Diagnostics, Inc - Book Value per Share|CNTG: Book Value per Share|enzo.com - Net Assets per Single Share|Net Assets per Share Fresh2 Group|GENE (Genetic Technologies Ltd) - Accounting Value per Share|Book Value per Share ME|Psychemedics Corp (PMD) - Net Assets per Single Share